These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 21465522)

  • 1. RUNX3 in oncogenic and anti-oncogenic signaling in gastrointestinal cancers.
    Ito K
    J Cell Biochem; 2011 May; 112(5):1243-9. PubMed ID: 21465522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of RUNX3 in bone morphogenetic protein signaling in colorectal cancer.
    Lee CW; Ito K; Ito Y
    Cancer Res; 2010 May; 70(10):4243-52. PubMed ID: 20442291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Runx3 protects gastric epithelial cells against epithelial-mesenchymal transition-induced cellular plasticity and tumorigenicity.
    Voon DC; Wang H; Koo JK; Nguyen TA; Hor YT; Chu YS; Ito K; Fukamachi H; Chan SL; Thiery JP; Ito Y
    Stem Cells; 2012 Oct; 30(10):2088-99. PubMed ID: 22899304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RUNX3 suppresses gastric epithelial cell growth by inducing p21(WAF1/Cip1) expression in cooperation with transforming growth factor {beta}-activated SMAD.
    Chi XZ; Yang JO; Lee KY; Ito K; Sakakura C; Li QL; Kim HR; Cha EJ; Lee YH; Kaneda A; Ushijima T; Kim WJ; Ito Y; Bae SC
    Mol Cell Biol; 2005 Sep; 25(18):8097-107. PubMed ID: 16135801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor suppressor, AT motif binding factor 1 (ATBF1), translocates to the nucleus with runt domain transcription factor 3 (RUNX3) in response to TGF-beta signal transduction.
    Mabuchi M; Kataoka H; Miura Y; Kim TS; Kawaguchi M; Ebi M; Tanaka M; Mori Y; Kubota E; Mizushima T; Shimura T; Mizoshita T; Tanida S; Kamiya T; Asai K; Joh T
    Biochem Biophys Res Commun; 2010 Jul; 398(2):321-5. PubMed ID: 20599712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Possible involvement of RUNX3 silencing in the peritoneal metastases of gastric cancers.
    Sakakura C; Hasegawa K; Miyagawa K; Nakashima S; Yoshikawa T; Kin S; Nakase Y; Yazumi S; Yamagishi H; Okanoue T; Chiba T; Hagiwara A
    Clin Cancer Res; 2005 Sep; 11(18):6479-88. PubMed ID: 16166423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oncogenic role of RUNX3 in head and neck cancer.
    Kudo Y; Tsunematsu T; Takata T
    J Cell Biochem; 2011 Feb; 112(2):387-93. PubMed ID: 21268058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RUNX3 attenuates beta-catenin/T cell factors in intestinal tumorigenesis.
    Ito K; Lim AC; Salto-Tellez M; Motoda L; Osato M; Chuang LS; Lee CW; Voon DC; Koo JK; Wang H; Fukamachi H; Ito Y
    Cancer Cell; 2008 Sep; 14(3):226-37. PubMed ID: 18772112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Claudin-1 has tumor suppressive activity and is a direct target of RUNX3 in gastric epithelial cells.
    Chang TL; Ito K; Ko TK; Liu Q; Salto-Tellez M; Yeoh KG; Fukamachi H; Ito Y
    Gastroenterology; 2010 Jan; 138(1):255-65.e1-3. PubMed ID: 19706291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of Runx3 is a key event in inducing precancerous state of the stomach.
    Ito K; Chuang LS; Ito T; Chang TL; Fukamachi H; Salto-Tellez M; Ito Y
    Gastroenterology; 2011 May; 140(5):1536-46.e8. PubMed ID: 21277301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular pathology of RUNX3 in human carcinogenesis.
    Subramaniam MM; Chan JY; Yeoh KG; Quek T; Ito K; Salto-Tellez M
    Biochim Biophys Acta; 2009 Dec; 1796(2):315-31. PubMed ID: 19682550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Runx3 controls growth and differentiation of gastric epithelial cells in mammals.
    Fukamachi H
    Dev Growth Differ; 2006 Jan; 48(1):1-13. PubMed ID: 16466388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The emerging role of RUNX3 in cancer metastasis (Review).
    Chen F; Liu X; Bai J; Pei D; Zheng J
    Oncol Rep; 2016 Mar; 35(3):1227-36. PubMed ID: 26708741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth regulation of gastric epithelial cells by Runx3.
    Fukamachi H; Ito K
    Oncogene; 2004 May; 23(24):4330-5. PubMed ID: 15156189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GASDERMIN, suppressed frequently in gastric cancer, is a target of LMO1 in TGF-beta-dependent apoptotic signalling.
    Saeki N; Kim DH; Usui T; Aoyagi K; Tatsuta T; Aoki K; Yanagihara K; Tamura M; Mizushima H; Sakamoto H; Ogawa K; Ohki M; Shiroishi T; Yoshida T; Sasaki H
    Oncogene; 2007 Oct; 26(45):6488-98. PubMed ID: 17471240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RUNX3 inhibits cell proliferation and induces apoptosis by reinstating transforming growth factor beta responsiveness in esophageal adenocarcinoma cells.
    Torquati A; O'rear L; Longobardi L; Spagnoli A; Richards WO; Daniel Beauchamp R
    Surgery; 2004 Aug; 136(2):310-6. PubMed ID: 15300196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RUNX3 is multifunctional in carcinogenesis of multiple solid tumors.
    Chuang LS; Ito Y
    Oncogene; 2010 May; 29(18):2605-15. PubMed ID: 20348954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Runx3 expression during mouse tongue and palate development.
    Yamamoto H; Ito K; Kawai M; Murakami Y; Bessho K; Ito Y
    Anat Rec A Discov Mol Cell Evol Biol; 2006 Jul; 288(7):695-9. PubMed ID: 16761282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Promoter hypermethylation of the RUNX3 gene in esophageal squamous cell carcinoma.
    Long C; Yin B; Lu Q; Zhou X; Hu J; Yang Y; Yu F; Yuan Y
    Cancer Invest; 2007 Dec; 25(8):685-90. PubMed ID: 18058463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The RUNX3 tumor suppressor upregulates Bim in gastric epithelial cells undergoing transforming growth factor beta-induced apoptosis.
    Yano T; Ito K; Fukamachi H; Chi XZ; Wee HJ; Inoue K; Ida H; Bouillet P; Strasser A; Bae SC; Ito Y
    Mol Cell Biol; 2006 Jun; 26(12):4474-88. PubMed ID: 16738314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.